Brief: First Wave BioPharma Announces First Patient Screened For Phase 2 Span Adrulipase Trial

GridAI Technologies

02/02/2023 13:23

Feb 2 (Reuters) - First Wave BioPharma Inc  FWBI.O :
    * FIRST WAVE BIOPHARMA ANNOUNCES FIRST PATIENT SCREENED FOR
PHASE
2 SPAN ADRULIPASE TRIAL IN CYSTIC FIBROSIS
    * FIRST WAVE BIOPHARMA INC - PATIENT DOSING IS EXPECTED TO
COMMENCE BY MID-FEBRUARY WITH TOPLINE RESULTS FROM STUDY TO BE
AVAILABLE BY MID-2023

Source text for Eikon:  ID:nGNX8LC2Gl 
Further company coverage:  FWBI.O 
 ((Reuters.Briefs@thomsonreuters.com;))